Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer
NCT00208273
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Letrozole - Concomitant
DRUG:
Letrozole - Sequential
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators
[object Object]